# Efficacy and Safety of Low-dose Ticagrelor

Study · id `cardio:ct-nct03381742` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03381742](<https://clinicaltrials.gov/study/NCT03381742>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03381742

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3043 participants.

## Technical summary

Registry record NCT03381742. Non-randomized; single masking; primary purpose treatment. Start 2017-12-13 (actual); primary completion 2018-12-13 (actual). Results posted on 2019-09-30.

## Key facts

- Design: Interventional study; non-randomized; single masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 3043 participants (enrolled count; ClinicalTrials.gov record NCT03381742, source copy `cardio:ctgov-nct03381742-2019-09-30`, retrieved 2026-10-26)
- Started: 2017-12-13 (actual) (ClinicalTrials.gov record NCT03381742, source copy `cardio:ctgov-nct03381742-2019-09-30`, retrieved 2026-10-26)
- Primary completion: 2018-12-13 (actual) (ClinicalTrials.gov record NCT03381742, source copy `cardio:ctgov-nct03381742-2019-09-30`, retrieved 2026-10-26)
- Completion: 2019-02-13 (actual) (ClinicalTrials.gov record NCT03381742, source copy `cardio:ctgov-nct03381742-2019-09-30`, retrieved 2026-10-26)
- Results first posted: 2019-09-30 (ClinicalTrials.gov record NCT03381742, source copy `cardio:ctgov-nct03381742-2019-09-30`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03381742, source copy `cardio:ctgov-nct03381742-2019-09-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03381742-2019-09-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of Low-dose Ticagrelor
- Condition: Coronary Artery Disease
- Intervention (Drug): Ticagrelor
- Intervention (Drug): ticagrelor
- Intervention (Drug): ticagrelor
- Intervention (Drug): clopidogrel
- Lead sponsor: First Affiliated Hospital of Harbin Medical University
- Lead sponsor class: OTHER
- Collaborator: Beijing Anzhen Hospital
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Dalian Medical University
- Collaborator class: OTHER
- Collaborator: The Central Hospital of Jia Mu Si City
- Collaborator class: UNKNOWN
- Collaborator: First Affiliated Hospital of Kunming Medical University
- Collaborator class: OTHER
- Collaborator: RenJi Hospital
- Collaborator class: OTHER
- Collaborator: Tianjin Medical University General Hospital
- Collaborator class: OTHER
- Collaborator: Weifang People's Hospital
- Collaborator class: OTHER
- Collaborator: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Collaborator class: OTHER
- Collaborator: Shengjing Hospital
- Collaborator class: OTHER
- Collaborator: Shaanxi Provincial People's Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: First Affiliated Hospital of Harbin Medical University (`cardio:org-first-affiliated-hospital-of-harbin-medical-university`)
- Registry lists this organization as a collaborator: Beijing Anzhen Hospital (`cardio:org-beijing-anzhen-hospital`)
- Registry lists this organization as a collaborator: The First Affiliated Hospital of Dalian Medical University (`cardio:org-the-first-affiliated-hospital-of-dalian-medical-university`)
- Registry lists this organization as a collaborator: First Affiliated Hospital of Kunming Medical University (`cardio:org-first-affiliated-hospital-of-kunming-medical-university`)
- Registry lists this organization as a collaborator: RenJi Hospital (`cardio:org-renji-hospital`)
- Registry lists this organization as a collaborator: Tianjin Medical University General Hospital (`cardio:org-tianjin-medical-university-general-hospital`)
- Registry lists this organization as a collaborator: Weifang People's Hospital (`cardio:org-weifang-people-s-hospital`)
- Registry lists this organization as a collaborator: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (`cardio:org-union-hospital-tongji-medical-college-huazhong-university-090806`)
- Registry lists this organization as a collaborator: Shengjing Hospital (`cardio:org-shengjing-hospital`)
- Registry lists this organization as a collaborator: Shaanxi Provincial People's Hospital (`cardio:org-shaanxi-provincial-people-s-hospital`)

## Provenance

Content hash: 48b89634a75597f13c56d3f16a7014be960d9d02168c1f8587e309fb99fb3e20
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
